You are viewing the site in preview mode

Skip to main content

Advertisement

Table 4 Yearly costs of pharmacological therapies* used in the PCP scenario, rounded to the nearest euro, by gender (2001 prices).

From: Cost-effectiveness analysis of guidelines for antihypertensive care in Finland

Pharmacological subgroup ATC code male female
hydrochlorothiazide or trichlormethiazide and potassium-sparing agents C03EA 40 42
beta-blocking agents C07A 145 136
combination of metoprolol or bisoprolol and thiazides C07B 141 141
atenolol or metoprolol and other antihypertensives C07F 285 275
calcium channel blockers C08 245 228
ACE inhibitors C09A 203 192
combination of ACE inhibitors and diuretics C09BA 233 228
combination of ACE inhibitors and calcium channel blockers C09BB 349 348
angiotensin II subtype 1 receptor antagonists C09C 251 250
combination of angiotensin II subtype 1 receptor antagonists and diuretics C09D 271 274
  1. *(weighted average of the different pharmacological subgroups)